Close Menu

NEW YORK ─ Randox Laboratories on Thursday announced it has invested £30 million ($33.7 million) in a specialized lab to enhance its capacity for SARS-CoV-2 testing.

The testing lab is part of a national testing program for COVID-19, which is a collaborative initiative involving government and partners within industry, Randox said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.